REVI

Device BLUEWIND MEDICAL
Total Payments
$2.1M
Transactions
1,878
Doctors
576
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $2.1M 1,878 576

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $1.6M 568 77.1%
Consulting Fee $354,396 71 16.9%
Travel and Lodging $79,557 303 3.8%
Food and Beverage $46,805 936 2.2%

Payments by Type

Research
$1.6M
568 transactions
General
$480,758
1,310 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
RESTORE: AN RCT TO EVAULATE THE EFFICACY OF THE REVI SYSTEM BLUEWIND MEDICAL $1.1M 0
BLUEWIND RENOVA ISTIM SYSTEM FOR THE TREATMENT OF OAB (OASIS) BLUEWIND MEDICAL $505,495 0

Top Doctors Receiving Payments for REVI

Doctor Specialty Location Total Records
Unknown Durham, NC $1.6M 568
, MD Urology Nashville, TN $176,655 62
, M.D Urology Scottsdale, AZ $146,599 70
, MD Urology Ann Arbor, MI $19,662 15
, M.D Urology Owings Mills, MD $11,856 11
, MD Urogynecology and Reconstructive Pelvic Surgery New York, NY $10,431 11
Eric Espinosa Urology Springfield, OH $6,854 13
, M.D Gynecology Omaha, NE $6,274 8
, M.D Obstetrics & Gynecology Durham, NC $4,622 7
, MD Urogynecology and Reconstructive Pelvic Surgery Orange, CA $2,081 3
, M.D Urology Cleveland, OH $2,010 9
, M.D Urology Salt Lake City, UT $1,853 4
, MD Urology Saint Louis, MO $1,621 7
, MD Urology Moorestown, NJ $1,530 7
, M.D Gynecology Kirkland, WA $1,528 7
, M.D Urology Minneapolis, MN $1,447 9
, MD Urology Round Rock, TX $1,397 7
, M.D Obstetrics & Gynecology Richmond Heights, OH $1,324 5
, M.D Urology Corona, CA $1,322 5
, M.D Urology Stanford, CA $1,322 9
, MD Urology Saint Peters, MO $1,290 10
, D.O Urology Leesburg, VA $1,249 7
, M.D Urology Boise, ID $1,181 6
, MD Student in an Organized Health Care Education/Training Program Cincinnati, OH $1,158 4
, MD Urology Gadsden, AL $1,154 11

About REVI

REVI is a device associated with $2.1M in payments to 576 healthcare providers, recorded across 1,878 transactions in the CMS Open Payments database. The primary manufacturer is BLUEWIND MEDICAL.

Payment data is available from 2024 to 2024. In 2024, $2.1M was paid across 1,878 transactions to 576 doctors.

The most common payment nature for REVI is "Unspecified" ($1.6M, 77.1% of total).

REVI is associated with 2 research studies, including "RESTORE: AN RCT TO EVAULATE THE EFFICACY OF THE REVI SYSTEM" ($1.1M).